Skip to main content
Clinical Trials/NCT05132543
NCT05132543
Not yet recruiting
Not Applicable

Studying Human Cognition and Neurological Disorders Using µECoG Electrodes

Duke University0 sites38 target enrollmentMay 1, 2026

Overview

Phase
Not Applicable
Intervention
High density micro-electrocorticography for neural speech prothesis
Conditions
Epilepsy
Sponsor
Duke University
Enrollment
38
Primary Endpoint
Percentage of phoneme decoding accuracy as measured by linear decoding model
Status
Not yet recruiting
Last Updated
last month

Overview

Brief Summary

The overall purpose of this study is to better understand human cognition and human epilepsy by working with patients undergoing clinical treatment for pharmacologically resistant epilepsy. The investigators will investigate human cognition by conducting controlled experiments that focus on sensory, motor, and cognitive phenomena such as sensory processing, memory, and language. The investigators will also examine the neural underpinnings of epilepsy during both sleep and wakefulness to better understand both the foundations of epilepsy and how epilepsy affects cognition. The investigators hope to use these data to have a better understanding of cognition, epilepsy, and how the two interact. This will potentially lead to better markers for seizure onsets as well as epilepsy more generally. For this research, the investigators will use μECoG arrays manufactured by commercial partners. These arrays have passed all major ISO 10993 bio-compatibility tests. Based on this characterization and use in the intraoperative setting (limited duration and supervised usage), these devices pose a minimal risk to participants. Data will be analyzed and protected using the Duke SSRI protected research data network.

Registry
clinicaltrials.gov
Start Date
May 1, 2026
End Date
September 15, 2027
Last Updated
last month
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Potential subjects will come from adult and pediatric patients (between the ages of 12 and 18) undergoing surgery for the treatment of pharmacologically resistant epilepsy, brain tumor resection, brain mass resection, or deep brain stimulation (DBS) for the first time
  • Proficient English speakers
  • No Major cognitive impairment

Exclusion Criteria

  • Previous DBS procedure
  • Subject unable to consent to study

Arms & Interventions

Wireless µECoG Prosthesis for Speech

Intervention: High density micro-electrocorticography for neural speech prothesis

Outcomes

Primary Outcomes

Percentage of phoneme decoding accuracy as measured by linear decoding model

Time Frame: Intraoperative data collection period, 20 minutes

Number of kriging resolution as measured by signal power.

Time Frame: Intraoperative data collection period, 20 minutes

Evoked signal-to-noise analysis human brain.

Time Frame: Intraoperative data collection period, 20 minutes

This study will compare the neural response sensitivity of intraoperative µECoG recording to those of in-unit recordings with macro-ECoG and SEEG. The strength and reliability of the high gamma (HG) response are critical for speech decoding algorithms. For all recordings, the HG power modulation ratio over baseline during speech perception and production will be measured and compared with non-parametric statistical tests.

Number of HG power modulation as measured by signal power.

Time Frame: Intraoperative data collection period, 20 minutes

Secondary Outcomes

  • Number of serious adverse events as measured by medical record review(Implantation to Three-months follow-up)

Similar Trials